ClinicalTrials.gov record

Terminated Not applicable Interventional Accepts healthy volunteers Results available

Central Pain Syndrome in Survivors of Head and Neck Cancer

ClinicalTrials.gov ID: NCT04128267

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT04128267. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 13, 2026, 1:14 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Characterization of Central Pain Syndrome in Survivors of Head and Neck Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a cross-sectional pilot study of head and neck cancer survivors who have completed multi-modal treatment to assess and characterize the presence of distinct pain syndromes.

Study identification

NCT ID: NCT04128267
Recruitment status: Terminated
Study type: Interventional
Phase: Not applicable
Lead sponsor: Vanderbilt-Ingram Cancer Center; Other
Enrollment: 32 participants

Conditions and interventions

Conditions

Head and Neck Cancer

Interventions

Device · Other

Eligibility (public fields only)

Age range: 21 Years and older
Sex: All
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Nov 4, 2019 (Actual)
Primary completion: Jul 21, 2022 (Actual)
Completion: Jul 21, 2022 (Actual)
Last update posted: Sep 19, 2022

2019 – 2022

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
Vanderbilt-Ingram Cancer Center	Nashville	Tennessee	37232	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT04128267, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Sep 19, 2022 · Synced Nov 13, 2026